Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY
· Real-Time Price · USD
1.08
0.14 (14.86%)
At close: Aug 15, 2025, 3:59 PM
1.05
-2.79%
After-hours: Aug 15, 2025, 07:06 PM EDT
Oncolytics Biotech Ratios and Metrics
Financials in CAD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -2.5 | -3.12 | -2.38 | -3.57 | -3.91 | -8.16 | -5.2 | -7.36 | -4.14 | -3.84 | -5.56 | -3.68 | -3.62 | -3.14 | -7.48 | -6.43 | -9.24 |
PEG Ratio | 0.09 | 0.37 | -0.09 | -0.86 | -0.06 | 0.13 | -0.31 | -0.33 | 0.14 | -0.05 | 0.39 | 0.10 | n/a | -0.05 | 0.23 | n/a | 0.23 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 10.31 | 16.72 | 10.02 | 5.65 | 4.70 | 4.67 | 7.12 | 9.86 | 3.93 | 4.96 | 3.45 | 2.44 | 3.19 | 2.70 | 3.41 | 4.01 | 5.32 |
P/FCF Ratio | -10.31 | -12.74 | -18.65 | -14.85K | -14.35 | -21.03 | -34.25 | -25.89 | -12.91 | -22.14 | -23.05 | -10.82 | -17.77 | -15.19 | -37 | -27.41 | -42.7 |
P/OCF Ratio | -10.31 | -12.75 | -18.78 | -15.18K | -14.44 | -21.04 | -34.25 | -25.89 | -12.92 | -22.14 | -23.1 | -10.84 | -17.87 | -15.37 | -39.03 | -27.44 | -42.7 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.15 | 0.18 | 0.12 | 0.06 | 0.05 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
Quick Ratio | 3.21 | 2.82 | 2.99 | 4.99 | 8.14 | 9.01 | 4.53 | 11.69 | 13.88 | 9.05 | 10.42 | 15.49 | 17.96 | 16.69 | 19.04 | 21.47 | 22.15 |
Current Ratio | 3.21 | 2.82 | 2.99 | 4.99 | 8.14 | 9.01 | 4.53 | 11.69 | 13.88 | 9.05 | 10.42 | 15.49 | 17.96 | 16.69 | 19.04 | 21.47 | 22.15 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -1.03 | -1.34 | -1.05 | -0.4 | -0.3 | -0.14 | -0.34 | -0.33 | -0.24 | -0.32 | -0.16 | -0.17 | -0.22 | -0.21 | -0.11 | -0.16 | -0.14 |
Return on Assets | -0.34 | -0.4 | -0.39 | -0.23 | -0.2 | -0.1 | -0.22 | -0.23 | -0.17 | -0.23 | -0.11 | -0.13 | -0.17 | -0.17 | -0.09 | -0.13 | -0.12 |
Return on Invested Capital | -0.49 | n/a | -0.59 | -0.31 | -0.28 | -0.26 | -0.3 | -0.24 | -0.19 | -0.25 | -0.17 | -0.18 | -0.17 | -0.17 | -0.12 | -0.12 | -0.11 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |